Skip to main content
. 2015 Sep 25;10(9):e0135969. doi: 10.1371/journal.pone.0135969

Fig 2. In vitro susceptibility to empirical intraperitoneal treatment.

Fig 2

A. Gram-positive organisms; B. Gram-negative organisms; P1, period 1 (1979–1992), n = 120 episodes; P2, period 2 (1993–2003), n = 125 episodes; P3, period 3 (2004–2014), n = 242 episodes; all variables are expressed as percentage.